How many clicks does 3.75mg Mounjaro take to inject?

The myth worth clearing up first: more clicks does not mean a higher dose

This one comes up often, and it's easy to see why. Many injectable devices work on a dial-and-click system where the number of clicks maps directly to units delivered. The Mounjaro KwikPen doesn't work that way. The dose is fixed and pre-set at manufacture. Clicking more times, holding longer, or pressing harder changes nothing about the amount of tirzepatide released. What the two-click process does is guide you through a reliable sequence: the first click drives the plunger, the second confirms the mechanism has completed its stroke.

That misunderstanding occasionally leads people to worry they've under-dosed, particularly when moving to 3.75mg for the first time. If you want a closer look at exactly how many clicks the 3.75mg Mounjaro pen produces and what each one means, we cover that in full detail on its own page. If your pen produced two clicks and the plunger is fully depressed, the injection is complete. You can read more about how the device behaves across all strengths on our Mounjaro clicks guide.

The NHS tirzepatide medicines page also signposts the Patient Information Leaflet as the definitive reference for technique, worth bookmarking, because the leaflet includes the exact page showing pen parts and step-by-step diagrams.

Where 3.75mg sits in the titration schedule, and why it exists

Licensed UK strengths of tirzepatide run from 2.5mg up to 15mg. The starting pen is 2.5mg, its purpose is to let your digestive system adjust gradually, reducing the nausea and discomfort that can appear in the first weeks of treatment. Most prescribers then move to 5mg after four weeks, which is when therapeutic weight-management effect begins in earnest.

The 3.75mg dose is used when a step up from 2.5mg to 5mg feels too sharp. Some people find the jump manageable; others experience renewed nausea at 5mg that settles if they spend an extra month at an intermediate level. A prescriber may recommend 3.75mg as a bridge in that situation. It is not a dose that appears in the standard licensed schedule, so it is only ever used under individual prescriber guidance, another reason the click count itself is less important than staying in close contact with your clinical team.

If you're weighing up how the Mounjaro schedule compares more broadly, our Mounjaro injection guide covers the full process from first use onwards.

Getting the two clicks right: practical technique

Technique matters more than click arithmetic. A few things that can affect whether the full dose is delivered:

First, the pen must be held firmly against the skin for the full duration of the injection, the leaflet specifies at least ten seconds after the second click before removing the pen. Lifting early is the most common reason a dose goes partially undelivered. Second, the injection site should be free of bruising, broken skin, or active lipohypertrophy (lumpy tissue from repeatedly injecting in the same spot). Rotating between the abdomen, thigh, and upper arm, as described in the SmPC on the eMC, reduces this risk. Third, the pen should come from the fridge and be allowed to reach room temperature for a short period before injecting, this makes the process more comfortable, though the exact window is in the leaflet rather than something to estimate.

Replacing the needle after each use matters too: a fresh needle ensures the full dose flows freely and reduces the risk of infection or injection-site pain. Our compatible replacement needles are available if you need to restock.

Questions about 3.75mg specifically (or about how many clicks appear in pens at other strengths) are covered on the KwikPen click count page. And if you're at an earlier stage of the schedule, the 1.25mg click guide walks through the same two-click process for that pen.

When to contact your prescriber rather than the Patient Information Leaflet

Injection technique questions are usually answerable by the leaflet. A few situations warrant going straight to your prescriber or the aftercare team instead. If you are unsure whether the dose was fully delivered (for instance the pen stopped mid-injection, or the site bled immediately afterwards) your clinical team can advise on next steps. Do not attempt a second injection to compensate without guidance.

Similarly, if nausea or gastrointestinal discomfort at 3.75mg is severe or persistent beyond the first two weeks, that is a prescriber conversation, not a technique adjustment. And any side effect that concerns you can be reported via the MHRA Yellow Card scheme, patients can submit reports directly, independent of their prescriber.

If you are still deciding whether tirzepatide treatment is right for you, a good starting point is the Mounjaro overview or our weight-loss treatment page. And when you're ready to speak with a prescriber, you can check your eligibility through our free consultation, a real clinician reviews every application the same day it comes in.